Daisuke Kotani

22PUBLICATIONS
150CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 20, 2026
Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer.

|Jun 08, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial.

|Aug 14, 2025
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer.

Chiara M L Loeffler, Hideaki Bando, Srividhya Sainath

|Feb 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

Hideaki Bando, Shogo Kumagai, Daisuke Kotani

|Nov 08, 2024
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan.

Yoshiaki Nakamura, Kristiyana Kaneva, Christine Lo

|Oct 19, 2024
Clinical usefulness of four-dimensional dynamic ventilation CT for borderline resectable locally advanced esophageal cancer.

Shioto Oda, Hirofumi Kuno, Takeo Fujita

Pageof 4

Frequent Collaborators

16 joint publications

Takayuki Yoshino

10 joint publications

Hideaki Bando

9 joint publications

Yoshiaki Nakamura

7 joint publications

Hiroya Taniguchi